These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15840831)

  • 1. Sensitivity of the folding/unfolding transition state ensemble of chymotrypsin inhibitor 2 to changes in temperature and solvent.
    Day R; Daggett V
    Protein Sci; 2005 May; 14(5):1242-52. PubMed ID: 15840831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of the unfolding transition state of chymotrypsin inhibitor 2 by molecular dynamics simulations.
    Li A; Daggett V
    J Mol Biol; 1996 Mar; 257(2):412-29. PubMed ID: 8609633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titration properties and thermodynamics of the transition state for folding: comparison of two-state and multi-state folding pathways.
    Tan YJ; Oliveberg M; Fersht AR
    J Mol Biol; 1996 Nov; 264(2):377-89. PubMed ID: 8951383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing nature of the protein folding transition state: implications for the shape of the free-energy profile for folding.
    Oliveberg M; Tan YJ; Silow M; Fersht AR
    J Mol Biol; 1998 Apr; 277(4):933-43. PubMed ID: 9545382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of experimental and calculated folding free energies for hydrophobic deletion mutants of chymotrypsin inhibitor 2: free energy perturbation calculations using transition and denatured states from molecular dynamics simulations of unfolding.
    Pan Y; Daggett V
    Biochemistry; 2001 Mar; 40(9):2723-31. PubMed ID: 11258883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the transition state for folding of a protein derived from experiment and simulation.
    Daggett V; Li A; Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1996 Mar; 257(2):430-40. PubMed ID: 8609634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the transition state of protein unfolding by use of molecular dynamics: chymotrypsin inhibitor 2.
    Li A; Daggett V
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10430-4. PubMed ID: 7937969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement of the position of the transition state in protein folding.
    Matouschek A; Otzen DE; Itzhaki LS; Jackson SE; Fersht AR
    Biochemistry; 1995 Oct; 34(41):13656-62. PubMed ID: 7577956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the energy landscape of protein folding/unfolding transition states.
    De Jong D; Riley R; Alonso DO; Daggett V
    J Mol Biol; 2002 May; 319(1):229-42. PubMed ID: 12051948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hammond behavior versus ground state effects in protein folding: evidence for narrow free energy barriers and residual structure in unfolded states.
    Sánchez IE; Kiefhaber T
    J Mol Biol; 2003 Apr; 327(4):867-84. PubMed ID: 12654269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing temperature accelerates protein unfolding without changing the pathway of unfolding.
    Day R; Bennion BJ; Ham S; Daggett V
    J Mol Biol; 2002 Sep; 322(1):189-203. PubMed ID: 12215424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding.
    Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):260-88. PubMed ID: 7490748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement of the intermediate and rate determining transition state of barnase on the energy landscape with changing temperature.
    Dalby PA; Oliveberg M; Fersht AR
    Biochemistry; 1998 Mar; 37(13):4674-9. PubMed ID: 9521788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein folding from a highly disordered denatured state: the folding pathway of chymotrypsin inhibitor 2 at atomic resolution.
    Kazmirski SL; Wong KB; Freund SM; Tan YJ; Fersht AR; Daggett V
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4349-54. PubMed ID: 11274353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism.
    Neira JL; Davis B; Ladurner AG; Buckle AM; Gay Gde P; Fersht AR
    Fold Des; 1996; 1(3):189-208. PubMed ID: 9079381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of the free energy barriers to two-state folding.
    Akmal A; Muñoz V
    Proteins; 2004 Oct; 57(1):142-52. PubMed ID: 15326600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding transition-state and denatured-state ensembles of FSD-1 from folding and unfolding simulations.
    Lei H; Dastidar SG; Duan Y
    J Phys Chem B; 2006 Nov; 110(43):22001-8. PubMed ID: 17064170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratcheted molecular-dynamics simulations identify efficiently the transition state of protein folding.
    Tiana G; Camilloni C
    J Chem Phys; 2012 Dec; 137(23):235101. PubMed ID: 23267502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is protein unfolding the reverse of protein folding? A lattice simulation analysis.
    Dinner AR; Karplus M
    J Mol Biol; 1999 Sep; 292(2):403-19. PubMed ID: 10493884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ethanol concentrations on temperature driven structural changes of chymotrypsin inhibitor 2.
    Mohanta D; Jana M
    J Chem Phys; 2016 Apr; 144(16):165101. PubMed ID: 27131567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.